Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
88 participants
INTERVENTIONAL
2014-02-05
2023-10-22
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Patients who meet the inclusion criteria will be informed about the study during their consultation at the 7th or 8th month, and their gynecologist will invite them to take part. If the answer is positive, the patients will be seen again at a specific consultation for the study between the 37th and 38the Weeks of amenorrhea at the maternity unit of Dijon CHU. During this consultation, the gynecologist will conduct a medical examination, while the Plurithematic clinical investigation center nurse will take a blood sample (3 x 6ml tubes and 1 x 7ml tube).
If labour has not started by 41 Weeks of amenorrhea, the patients will be seen at another consultation (consultation programmed in the usual follow-up of pregnancy) and a second blood sample (1 x 6ml tube and 1 x 7ml) will be taken.
The patients will be followed until childbirth and will be split into two groups according to whether or not they gave birth after the onset of spontaneous labour.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Methods of Labor Induction and Perinatal Outcomes
NCT02477085
Outpatient Induction of Labour Using a Double Balloon Transcervical Catheter in Low-risk Pregnant Women: a Two-centre Open Prospective Randomised Controlled Trial - OutCRIB
NCT07265518
Obesity Study to Assess Induction of Labor
NCT03796416
Randomized Controlled Trial: Induction of Labour of Obese Women With Dinoprostone or Single Balloon Catheter
NCT01962831
Study on Initiation and Immunological Mechanism of Childbirth
NCT05604768
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients with pre-conceptional obesity
Blood samples at 37-38 Weeks of amenorrhea
Blood samples at 41 Weeks of amenorrhea if prolonged pregnancy
Blood samples at the time of delivery
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Blood samples at 37-38 Weeks of amenorrhea
Blood samples at 41 Weeks of amenorrhea if prolonged pregnancy
Blood samples at the time of delivery
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Please affiliated to a social security scheme
* Body Mass Index Preconception ≥ 30 kg / m²
* Age\> 18 years
* Unique Pregnancy
* Having a plot of Normal Fetal heart rate
Exclusion Criteria
* Scheduled Caesarean
* Infectious Disease suspected or proven, including HIV infection, hepatitis C, hepatitis B
* Pathology inflammatory or autoimmune
* Anti-inflammatory or immunosuppressive therapy
* Patient under guardianship
* Patient in safeguarding justice
* Caesarean section before labor
* Delivery before 37 Weeks of amenorrhea
* Anti-inflammatory or immunosuppressive therapy during study participation
* Fetal Heart Rate abnormal during study participation
* Premature rupture of fetal membranes without formal labor spontaneously within 48 hours
* Induction of labor or cervical ripening before 41SA
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire Dijon
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU de DIJON
Dijon, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
WENDREMAIRE APJ 2013
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.